natrecor การใช้

• The first vials of Natrecor shipped in mid-August.
• Brewer said the agency decided Scios had not tested Natrecor on enough patients.
• Brewer is confident the data prove Natrecor works better.
• Like Scios, Natrecor has had a rocky history.
• Analysts estimate that sales of Natrecor could reach $ 300 million a year.
• A vial of Natrecor will cost about $ 250.
• Natrecor is a truly unique product for a largely underserved and growing market.
• Natrecor is a genetically engineered version of a protein secreted by a failing heart.
• Natrecor is a bioengineered form of a natural hormone that helps dilate blood vessels.
• While SCIO-469 undergoes tests, Brewer is creating a market for Natrecor.
• But doctors will have to use Natrecor carefully.
• Natrecor would be Scios'first drug approval after more than 15 years of research.
• This week, 20 months after Natrecor was rejected, Scios will request FDA reconsideration.
• Lehman Brothers and other Wall Street firms expect Natrecor to receive final approval this summer.
• Brewer has set modest expectations for Natrecor.
• Scios stock rose when the drug, Natrecor, show positive results in Phase III trials.
• Studies showed patients could breathe better as blood circulation and lung congestion improved with Natrecor treatment.
• He said the market for Natrecor could reach $ 200 million to $ 300 million a year.
• But the FDA ignored the panel's advice and told Scios that Natrecor needed more tests.
• The money will fund the sales effort for Natrecor _ and clinical trials for SCIO-469.